B · Normal
[AbbVie's third quarter revenue was US$17.4 billion, adjusted earnings per share of US$3.82] On October 30, AbbVie announced its financial results for the third quarter of 2026. During the period, it achieved net revenue of US$17.404 billion, a year-on-year increase of 10.3%; GAAP diluted earnings per share was US$2.37, a year-on-year increase of more than 100%; adjusted diluted earnings per share was US$3.82, a year-on-year increase of more than 100%. The above-mentioned adjusted earnings per share includes a negative impact of $0.11 from the acquisition of research and development projects and milestone expenses.
U.S. stock trends 🕐 2026-10-30 19:50
#U.S. stock trends
Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇
← Back to Telegraph

Related telegraphs

[Wells Fargo lowered the target price of many U.S. technology companies, with Sa 10-30 20:01 On October 30, US broker PIPER SANDLER was authorized to repurchase shares of up 10-30 19:59 On October 30, Haina International lowered Intel’s target price from US$105 to U 10-30 19:54 On October 30, Ruijie Financial lowered the target price of Amazon from US$300 t 10-30 19:54 [Goldman Sachs maintains Apple's "buy" rating and raises its 12-month target pri 10-30 19:49 On October 30, AbbVie expected full-year adjusted earnings per share of 13.95 to 10-30 19:48

Comments

0/500
Captcha (click to refresh)
No comments yet